http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-248586-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_334f3ee6eeb9c496c3cce8c9fc4532f0
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D273-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D229-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-00
filingDate 1986-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b17c01311ba5e0943a1eb4631fc4a33e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d8d0a8c10fe158121dc84e98f84dd26
publicationDate 1987-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-248586-A1
titleOfInvention PROCESS FOR PREPARING HETEROCYCLICALLY SUBSTITUTED GUANIDINE DERIVATIVES
abstract The present invention relates to a process for the preparation of heterocyclic substituted guanidine derivatives. The aim of the invention is to develop a universeingueltiges process for the production of different representatives of this class, which was previously accessible only in exceptional cases, develop. The object is achieved by reacting N-substituted guanyl-dithiocarbimide diesters with binuclophiles. The representatives of the class of substances according to the invention are potential biocides which are of particular interest for the synthesis of pharmaceuticals. The advantage of the invention is the direct synthesis of a large number of representatives of the heterocyclic substituted guanidine derivatives with a broad substituent pattern from technically readily accessible starting materials.
priorityDate 1986-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135436526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6058
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86287517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410541363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407914953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457578503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID426307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426088130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425613610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519714

Total number of triples: 42.